| Product NDC: | 60977-116 |
| Proprietary Name: | Ativan |
| Non Proprietary Name: | lorazepam |
| Active Ingredient(s): | 2 mg/mL & nbsp; lorazepam |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60977-116 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018140 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090924 |
| Package NDC: | 60977-116-02 |
| Package Description: | 10 VIAL in 1 PACKAGE (60977-116-02) > 10 mL in 1 VIAL (60977-116-01) |
| NDC Code | 60977-116-02 |
| Proprietary Name | Ativan |
| Package Description | 10 VIAL in 1 PACKAGE (60977-116-02) > 10 mL in 1 VIAL (60977-116-01) |
| Product NDC | 60977-116 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lorazepam |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20090924 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | LORAZEPAM |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |